منابع مورد استفاده در این مطلب
(2017 Sep 25, Revised). Breast Cancer Gene Expression Tests. American Cancer Society. Available online at https://www.cancer.org/cancer/breast-cancer/understanding-a-breast-cancer-diagnosis/breast-cancer-gene-expression.php. Accessed on Feb 2018.
Chalasani, P. (Mar 08, 2018 Updated). Breast Cancer. Medscape Drugs and Diseases. Available online at http://emedicine.medscape.com/article/1947145-overview. Accessed on Feb 2018.
Bartless, J. et al. (2016 April 27). Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others. JNCI J Natl Cancer Inst (2016) 108(9): djw050. Available online at https://www.ncbi.nlm.nih.gov/pubmed/27130929. Accessed on Feb 2018.
(2015 November 4). Tumor Markers. National Cancer Institute. Available online at https://www.cancer.gov/about-cancer/diagnosis-staging/diagnosis/tumor-markers-fact-sheet. Accessed on Feb 2018.
Factor, R. (2018 Feb Updated). Breast Cancer. ARUP Consult. Available online at https://arupconsult.com/content/breast-cancer. Accessed on Feb 2018.
Selli, C. et. al. (2016). Accurate Prediction of Response to Endocrine Therapy in Breast Cancer Patients. Medscape News & Perspective from Breast Cancer Res. 2016;18(118). Available online at http://www.medscape.com/viewarticle/877996_1. Accessed on Feb 2018.
Douglas, D. (2017 March 23). Gene Profile Sways Breast Cancer Chemo Decisions. Medscape News & Perspective. Available online at http://www.medscape.com/viewarticle/877575. Accessed on Feb 2018.
Harris, L. et. al. (2016 April). Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline. Clinical Oncology 34, no. 10 (April 2016) 1134-1150. Available online at http://ascopubs.org/doi/full/10.1200/jco.2015.65.2289. Accessed Feb 2018.
Krop I, et.al. Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update. Journal of Clinical Oncology 35, no. 24 (August 2017) 2838-2847. Available online at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846188/. Accessed Feb 2018.
Cancer.Net. Breast Cancer: Diagnosis. Available online at https://www.cancer.net/cancer-types/breast-cancer/diagnosis. Accessed Feb 2018.
منابع مورد استفاده در بررسیهای قبلی
Pagana, Kathleen D. & Pagana, Timothy J. (© 2007). Mosby's Diagnostic and Laboratory Test Reference 8th Edition: Mosby, Inc., Saint Louis, MO. Pp 198-199.
Clarke, W. and Dufour, D. R., Editors (2006). Contemporary Practice in Clinical Chemistry, AACC Press, Washington, DC. 243-244.
Harris, L. et. al. (2007 November 20). American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer. Journal of Clinical Oncology v25(33) [On-line journal article]. Available online at http://jco.ascopubs.org/cgi/reprint/JCO.2007.14.2364v1. Accessed on 12/9/07.
(2007 May 14). Test Determines Risk of Breast Cancer Returning. FDA Consumer Update [On-line information]. Available online at http://www.fda.gov/consumer/updates/breastcan051407.html. Accessed on 12/9/07.
(© 2007). Oncotype DX FAQ. Genomic Health [On-line information]. Available online at http://www.genomichealth.com/oncotype/faq/hcp.aspx. Accessed on 12/9/07.
(© 2007). About Oncotype DX. Genomic Health [On-line information]. Available online at http://www.genomichealth.com/oncotype/about/hcp.aspx. Accessed on 12/9/07.
FDA clears MammaPrint test for marketing. News-Medical.Net [On-line information]. Available online at http://www.news-medical.net/?id=21736. Accessed on 12/9/07.
Detailed Guide: Breast Cancer. American Cancer Society [On-line information]. Available online at http://www.cancer.org/docroot/CRI/CRI_2_3x.asp?dt=5. Accessed on 12/9/07.
Barr, H. et. al. (2007 May 31). Breast Cancer Module I: Breast Anatomy, Physiology, and Pathology CME/CE. Medscape CME [On-line information]. Available online at http://www.medscape.com/viewarticle/548921. Accessed on 12/9/07.
(2007 October 10). Breast Cancer Statistics. CDC [On-line information]. Available online at http://www.cdc.gov/cancer/breast/statistics/%20. Accessed on 6/8/08.
(2008 June 2). Genomic Health Announces Expansion of Oncotype DX(R) Breast Cancer Test to Include Quantitative Estrogen Receptor (ER) and Progesterone Receptor (PR) Scores. Genomic Health [On-line Press Release]. Available online at http://investor.genomichealth.com/ReleaseDetail.cfm?ReleaseID=313338. Accessed on 6/8/08.
(2006 December). Breast Cancer Gene Expression Ratio (HOXB13:IL17BR). Quest Diagnostics, Nichols Institute [On-line information]. PDF available for download at http://www.nicholsinstitute.com/HematologyOncology/BreastCancerCombo.pdf. Accessed on 6/8/08.
Cancer of the Breast. NCI, Surveillance Epidemiology and End Results Stat Fact Sheets [On-line information]. Available online at http://seer.cancer.gov/statfacts/html/breast.html. Accessed on 6/8/08.
(2006 May 23). The TAILORx Breast Cancer Trial. NCI [On-line information]. Available online at http://www.cancer.gov/clinicaltrials/digestpage/TAILORx. Accessed on 6/1/08.
(2006 May 23). Personalized Treatment Trial for Breast Cancer Launched. NCI [On-line information]. Available online at http://www.cancer.gov/newscenter/pressreleases/TAILORxRelease. Accessed on 6/1/08.
(2008 February 29). New Study of Targeted Therapies for Breast Cancer Establishes Model for Global Clinical Trials. NCI [On-line information]. Available online at http://www.cancer.gov/newscenter/pressreleases/ALTTO. Accessed on 6/1/08.
Vachani, C. (2007). Predicting Cancer Recurrence. OncoLink [On-line information]. Available online at http://www.oncolink.org/resources/article.cfm?c=16&s=59&ss=224&id=932. Accessed on 6/1/08.
Marchionni, L. et. al. (2008 March 4). Annals of Internal Medicine [On-line information]. Available online at http://www.annals.org/cgi/content/full/0000605-200803040-00208v1. Accessed on 6/1/08.
Gregory J. Tsongalis, Ph.D., HCLD, FACB. Director, Molecular Pathology, Co-Director, Pharmacogenomics Program, Associate Professor of Pathology, Dartmouth Medical School, Dartmouth Hitchcock Medical Center, Lebanon, NH.
Moynihan, T. (2012 July 10). Gene expression profiling for breast cancer: What is it? Mayo Clinic [On-line information]. Available online at http://www.mayoclinic.com/health/gene-expression-profiling/AN02081. Accessed January 2013.
(Reviewed 2011 October 21). Genetic Testing, Health Professionals: More About the EGAPP™ Tumor Gene Expression Profiling To Predict Risk of Breast Cancer Recurrence Recommendation. CDC [On-line information]. Available online at http://www.cdc.gov/genomics/gtesting/EGAPP/recommend/GEP_provider.htm. Accessed January 2013.
(Reviewed 2012 August 23). Breast Cancer. American Cancer Society [On-line information]. Available online at http://www.cancer.org/Cancer/BreastCancer/DetailedGuide/breast-cancer-diagnosis. Accessed January 2013.
EGAPP Working Group (2009 January). Recommendations from the EGAPP Working Group: can tumor gene expression profiling improve outcomes in patients with breast cancer? Genetics in Medicine v 11(1) [On-line information]. PDF available for download at http://www.egappreviews.org/docs/EGAPPWG-BrCaGEPRec.pdf. Accessed January 2013.
National Comprehensive Cancer Network. Guidelines for patients, Breast cancer (version 2, 2011). Available online at http://www.nccn.com/files/cancer-guidelines/breast/index.php#/22/. Accessed January 2013.
(©2011) Mammaprint, Breast Cancer Recurrence Assay. Agendia. Available online at http://www.agendia.com/pages/mammaprint/21.php. Accessed January 2013.